Adherence Interventions for HIV Youth Via Text & Cell Phone - Sequential Multiple Assignment Randomized Trial (SMART)

Sponsor
Florida State University (Other)
Overall Status
Completed
CT.gov ID
NCT03535337
Collaborator
Children's Hospital Los Angeles (Other), Hunter College of City University of New York (Other), Wayne State University (Other)
83
1
8
44.9
1.8

Study Details

Study Description

Brief Summary

The purpose of this study is to test an adaptive adherence intervention, which utilizes two mobile health (mHealth) intervention designs, in an effort to promote adherence to antiretroviral therapy (ART) and achieve and maintain viral load (VL) suppression in youth living with HIV (YLH) while increasing understanding of the context for wide-scale implementation of cell phone support (CPS) and text messaging support (SMS), with and without incentives.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CPS
  • Behavioral: SMS
N/A

Detailed Description

The study will consist of two points of randomization. The first step involves randomization of participants to receive either CPS or SMS using a 1:1 allocation ratio. Both intervention conditions will receive 3 months of intervention (i.e., 12 weeks of CPS or SMS).

The second step involves a stratified randomization in blocks with 8 possible intervention trajectories. Within each condition, participants are categorized into two groups - responders with VL<200 (Rsp) and non-responders with VL ≥200 (NRsp). Responders in the CPS condition will be randomly assigned to receive either 3 months of CPS tapered (CPS-T) intervention followed by standard care (SC) or only SC. Similarly, responders in the SMScondition will be randomly assigned to receive either 3 months of SMS tapered (SMS-T) intervention followed by SC or only SC. Non-responders in both CPS and SMS conditions will be randomly assigned to receive either 3 months of incentivized CPS (CPS-I) followed by 3 months of CPS-T and 3 months of SC or 3 months of incentivized SMS (SMS-I) followed by 3 months of SMS-T and 3 months of SC.

Study Design

Study Type:
Interventional
Actual Enrollment :
83 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Multiple Assignment Randomized TrialMultiple Assignment Randomized Trial
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Messaging and Cell Phone Support Embedded Within the Sequential Multiple Assignment Randomized Trial (SMART) Design
Actual Study Start Date :
Sep 1, 2018
Actual Primary Completion Date :
May 31, 2022
Actual Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: CPS-Rsp-T

After 3 months of intervention, this group of CPS Rsp will receive 3 months of CPS-T intervention followed by SC.

Behavioral: CPS
Assessment of participant's medication adherence and barrier problem solving via phone conversation

Active Comparator: CPS-Rsp-SC

After 3 months of intervention, this group of CPS Rsp's intervention will discontinue and they'll receive SC only

Behavioral: CPS
Assessment of participant's medication adherence and barrier problem solving via phone conversation

Active Comparator: CPS-NRsp-I

After 3 months of intervention, this group of CPS NRsp will receive 3 months of CPS-I followed by 3 months of CPS-T and 3 months of SC.

Behavioral: CPS
Assessment of participant's medication adherence and barrier problem solving via phone conversation

Active Comparator: CPS-NRsp-SMS-I

After 3 months of intervention, this group of CPS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC

Behavioral: CPS
Assessment of participant's medication adherence and barrier problem solving via phone conversation

Active Comparator: SMS-Rsp-T

After 3 months of intervention, this group of SMS Rsp will receive 3 months of SMS tapered (SMS-T) intervention followed by SC.

Behavioral: SMS
Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.

Active Comparator: SMS-Rsp-SC

After 3 months of intervention, this group of SMS Rsp, intervention will discontinue and they'll receive SC only

Behavioral: SMS
Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.

Active Comparator: SMS-NRsp-CPS-I

After 3 months of intervention, this group of SMS NRsp will receive 3 months of CPS-I followed by 3 months CPS-T and 3 months SC

Behavioral: SMS
Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.

Active Comparator: SMS-NRsp-I

After 3 months of intervention, this group of SMS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC

Behavioral: SMS
Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.

Outcome Measures

Primary Outcome Measures

  1. Viral Load Comparison [3 months]

    Viral Load (VL) suppression rate will be compared between the CPS and SMS groups using an X2 test. Also the drop in VL will be compared between the two groups.

Secondary Outcome Measures

  1. Medication Adherence Rate [3 months]

    Medication adherence rates will be compared between CPS and SMS groups, focusing on non-responders.

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 24 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • HIV diagnosis

  • Viral load ≥ 200 copies/mL within 3 months prior to enrollment or self-reported adherence ≤ 80%

  • ART medication regimen prescribed minimum of 3 months prior to eligibility VL or self-reported adherence

  • Sole owner of device capable of sending/receiving calls and text messages

  • Willingness to permit research team to communicate with their HIV care provider team

Exclusion Criteria:
  • Mental, physical, or emotional capacity prevents completion of protocol as written

  • Inability to understand written/spoken English

  • Concurrent participant in any adherence behavioral research intervention

Contacts and Locations

Locations

Site City State Country Postal Code
1 The City University of New York New York New York United States 10018

Sponsors and Collaborators

  • Florida State University
  • Children's Hospital Los Angeles
  • Hunter College of City University of New York
  • Wayne State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sylvie Naar, Principal Investigator, Florida State University
ClinicalTrials.gov Identifier:
NCT03535337
Other Study ID Numbers:
  • ATN 144
First Posted:
May 24, 2018
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sylvie Naar, Principal Investigator, Florida State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2022